212 related articles for article (PubMed ID: 17854248)
1. Pramipexole in psychiatry: a systematic review of the literature.
Aiken CB
J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
4. Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient.
Khan W; Rana AQ
Pharm World Sci; 2010 Apr; 32(2):114-6. PubMed ID: 20039208
[TBL] [Abstract][Full Text] [Related]
5. Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding.
Vitale C; Trojano L; Barone P; Errico D; Agosti V; Sorrentino G; Grossi D; Santangelo G
Behav Neurol; 2013 Jan; 27(4):559-62. PubMed ID: 23242361
[TBL] [Abstract][Full Text] [Related]
6. [Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: a case report].
Meriç C; Pirdoğan E; Günday Toker Ö; Tekin A; Bakım B; Çelik S
Turk Psikiyatri Derg; 2014; 25(3):212-4. PubMed ID: 25219695
[TBL] [Abstract][Full Text] [Related]
7. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
Lyons KE; Pahwa R
Mov Disord; 2009 Oct; 24(14):2121-7. PubMed ID: 19768728
[TBL] [Abstract][Full Text] [Related]
8. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
9. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Etminan M; Samii A; Takkouche B; Rochon PA
Drug Saf; 2001; 24(11):863-8. PubMed ID: 11665873
[TBL] [Abstract][Full Text] [Related]
11. Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
Bostwick JM; Hecksel KA; Stevens SR; Bower JH; Ahlskog JE
Mayo Clin Proc; 2009 Apr; 84(4):310-6. PubMed ID: 19339647
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Sporn J; Ghaemi SN; Sambur MR; Rankin MA; Recht J; Sachs GS; Rosenbaum JF; Fava M
Ann Clin Psychiatry; 2000 Sep; 12(3):137-40. PubMed ID: 10984002
[TBL] [Abstract][Full Text] [Related]
13. A review of pramipexole and its clinical utility in Parkinson's disease.
Biglan KM; Holloway RG
Expert Opin Pharmacother; 2002 Feb; 3(2):197-210. PubMed ID: 11829733
[TBL] [Abstract][Full Text] [Related]
14. Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone?
Fernandez HH; Merello M
Lancet Neurol; 2010 Jun; 9(6):556-7. PubMed ID: 20452824
[No Abstract] [Full Text] [Related]
15. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
16. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease.
Kumru H; Iranzo A; Carrasco E; Valldeoriola F; Marti MJ; Santamaria J; Tolosa E
Sleep; 2008 Oct; 31(10):1418-21. PubMed ID: 18853939
[TBL] [Abstract][Full Text] [Related]
17. Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Keränen T; Tuhkasaari M; Kuusisto H
Eur J Clin Pharmacol; 2009 Sep; 65(9):955-6; author reply 957. PubMed ID: 19415250
[No Abstract] [Full Text] [Related]
18. A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist.
Salas RE; Allen RP; Earley CJ; Gamaldo CE
Sleep; 2009 May; 32(5):587-8. PubMed ID: 19480224
[No Abstract] [Full Text] [Related]
19. Pramipexole extended-release: a review of its use in patients with Parkinson's disease.
Frampton JE
Drugs; 2014 Dec; 74(18):2175-90. PubMed ID: 25385556
[TBL] [Abstract][Full Text] [Related]
20. A case of mania following the use of pramipexole.
Sharma V; Smith A
Am J Psychiatry; 2007 Feb; 164(2):351. PubMed ID: 17267809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
